Domestication of chemistry by design of safer chemicals: structure-activity relationships.
暂无分享,去创建一个
[1] R. Jones,et al. Structure-genotoxicity relationship for aliphatic epoxides. , 1983, Biochemical pharmacology.
[2] B. Du. Commentary: drug metabolism and pharmacogenetics. , 1983 .
[3] D. Jerina,et al. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes. , 1983, Molecular pharmacology.
[4] P. Timmermans. Stereochemistry and Biological Activity of Drugs , 1983 .
[5] S. Toon,et al. Structure-pharmacokinetic relationships among the barbiturates in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.
[6] Gary M Williams,et al. Cellular systems for toxicity testing. , 1983, Annals of the New York Academy of Sciences.
[7] W. P. Gordon,et al. Comparison of hepatic biotransformation and toxicity of allyl alcohol and [1,1-2H2]allyl alcohol in rats. , 1983, Drug metabolism and disposition: the biological fate of chemicals.
[8] A. Renwick. CHAPTER 6 – Unmetabolized Compounds , 1983 .
[9] R. Prough,et al. CHAPTER 1 – Metabolic Formation of Toxic Metabolites* , 1983 .
[10] F. Guengerich,et al. Applications of theoretical chemistry in the prediction of metabolism , 1983 .
[11] B. Testa. CHAPTER 5 – Nonenzymatic Biotransformation , 1983 .
[12] F. Oesch,et al. CHAPTER 13 – Enzymes in Selective Toxicity , 1983 .
[13] G. Cohen. CHAPTER 12 – Metabolic Basis of Target Organ Toxicity , 1983 .
[14] M. Penno,et al. CHAPTER 14 – Intraindividual and Interindividual Variations* , 1983 .
[15] K. Pang. CHAPTER 8 – Fate of Xenobiotics: Physiologic and Kinetic Considerations* , 1983 .
[16] T. Campbell,et al. CHAPTER 10 – Impact of Nutrition on Detoxication , 1983 .
[17] J. Caldwell,et al. Biological basis of detoxication , 1983 .
[18] D. Jerina. The 1982 Bernard B. brodie Award Lecture. Metabolism of Aromatic hydrocarbons by the cytochrome P-450 system and epoxide hydrolase. , 1983, Drug metabolism and disposition: the biological fate of chemicals.
[19] H. Bolt,et al. Covalent protein binding of vinyl chloride metabolites during co-incubation of freshly isolated hepatocytes and hepatic sinusoidal cells of rats. , 1983, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[20] S. Safe,et al. The effects of twenty-two organochlorine pesticides as inducers of the hepatic drug-metabolizing enzymes. , 1983, General pharmacology.
[21] M. Correia,et al. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. , 1983, Annual review of pharmacology and toxicology.
[22] W G Richards,et al. Computer-aided molecular design. , 1983, Endeavour.
[23] D. Henschler,et al. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.
[24] E. Mimnaugh,et al. Activation of pharmacologic agents to radical intermediates. Implications for the role of free radicals in drug action and toxicity. , 1982, Biochemical pharmacology.
[25] Harvey Rg. Polycyclic hydrocarbons and cancer. , 1982 .
[26] S. Nelson,et al. Metabolic activation and drug toxicity. , 1982, Journal of medicinal chemistry.
[27] J. Venter. Immobilized and insolubilized drugs, hormones, and neurotransmitters: properties, mechanisms of action and applications. , 1982, Pharmacological reviews.
[28] J. Holtzman,et al. Minireview: role of reactive oxygen and metabolite binding in drug toxicity. , 1982, Life sciences.
[29] A. Wendel,et al. Chapter 16 – Metabolism of Organic Hydroperoxides , 1982 .
[30] E. Heymann. Chapter 12 – Hydrolysis of Carboxylic Esters and Amides , 1982 .
[31] F. J. D. Carlo. Metabolism, Pharmacokinetics, and Toxicokinetics Defined , 1982 .
[32] Ariens Ej,et al. 2 – General Principles of Nutritional Toxicology , 1982 .
[33] A. Dipple,et al. Selectivity of alkylation and aralkylation of nucleic acid components. , 1982, Drug metabolism reviews.
[34] B. Testa. Nonenzymatic contributions to xenobiotic metabolism. , 1982, Drug metabolism reviews.
[35] R. Hanzlik. Effects of substituents on reactivity and toxicity of chemically reactive intermediates. , 1982, Drug metabolism reviews.
[36] D. Jerina,et al. Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. , 1982, Drug metabolism reviews.
[37] W. Colburn,et al. Pharmacokinetics of drugs during various detoxification procedures for overdose and environmental exposure. , 1982, Drug metabolism reviews.
[38] J. Essigmann,et al. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. , 1982, Drug metabolism reviews.
[39] B. Ketterer. The role of nonenzymatic reactions of glutathione in xenobiotic metabolism. , 1982, Drug metabolism reviews.
[40] P. Deisler. A goal-oriented approach to reducing industrially related carcinogenic risks. , 1982, Drug metabolism reviews.
[41] G. Tognoni,et al. Epidemiological problems with TCDD (a critical view). , 1982, Drug metabolism reviews.
[42] J. Gillette. The problem of chemically reactive metabolites. , 1982, Drug metabolism reviews.
[43] B. Schwetz,et al. Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). , 1982, Drug metabolism reviews.
[44] A Poland,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.
[45] W. Trager. The postenzymatic chemistry of activated oxygen. , 1982, Drug metabolism reviews.
[46] N. Finch. Toxicological considerations for the medicinal chemist , 1981, Medicinal research reviews.
[47] R. Hanzlik. Reactivity and toxicity among halogenated methanes and related compounds. A physicochemical correlate with predictive value. , 1981, Biochemical pharmacology.
[48] A. E. Ahmed,et al. Covalent binding of [14C]benzene to cellular organelles and bone marrow nucleic acids. , 1981, Biochemical pharmacology.
[49] H. Benschop,et al. GLC-analysis and pharmacokinetics of the four stereoisomers of soman , 1981 .
[50] G. Gordon,et al. Glutathione synthetase–deficient lymphocytes and acetaminophen toxicity , 1981, Clinical pharmacology and therapeutics.
[51] R. A. Neal,et al. Inactivation of rat liver cytochrome P-450 by the suicide substrates parathion and chloramphenicol. , 1981, Drug metabolism reviews.
[52] B. Testa,et al. Inhibitors of Cytochrome P-450s and their mechanism of action. , 1981, Drug metabolism reviews.
[53] D. Henschler,et al. Structure-activity relationship in halogen and alkyl substituted allyl and allylic compounds: correlation of alkylating and mutagenic properties. , 1980, Biochemical pharmacology.
[54] D. Henschler,et al. Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and direct in vitro mutagenic properties. , 1980, Biochemical pharmacology.
[55] J. Feijen,et al. Polymeric Drug Delivery Systems , 1980 .
[56] P. Lewi. Multivariate Data Analysis in Structure—Activity Relationships , 1980 .
[57] S. Yalkowsky,et al. A Physical Chemical Basis for the Design of Orally Active Prodrugs , 1980 .
[58] E. J. Ariëns. Design of Safer Chemicals , 1980 .
[59] S. Unger. Consequences of the Hansch Paradigm for the Pharmaceutical Industry , 1980 .
[60] H. Wolf,et al. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines. , 1980, Scandinavian journal of urology and nephrology.
[61] E. LaVoie,et al. Structure-mutagenicity relationships of N-oxidized derivatives of aniline, o-toluidine, 2'-methyl-4-aminobiphenyl, and 3,2'-dimethyl-4-aminobiphenyl. , 1979, Journal of medicinal chemistry.
[62] Y. Martin,et al. Chapter 1 – Advances in the Methodology of Quantitative Drug Design , 1979 .
[63] A. R. Jones,et al. Epoxides as Obligatory Intermediates in the Metabolism of α-Halohydrins , 1979 .
[64] J. F. Miranda,et al. The Pharmacon-Receptor-Effector Concept , 1979 .
[65] Bruce R. Kowalski,et al. The Application of Pattern Recognition to Drug Design , 1979 .
[66] K Bergman,et al. Whole-body autoradiography and allied tracer techniques in distribution and elimination studies of some organic solvents: benzene, toluene, xylene, styrene, methylene chloride, chloroform, carbon tetrachloride and trichloroethylene. , 1979, Scandinavian journal of work, environment & health.
[67] V. Ray. Application of microbial and mammalian cells to the assessment of mutagenicity. , 1978, Pharmacological reviews.
[68] Ariens Ej,et al. Changes in plasma albumin concentration and drug action , 1978 .
[69] S. Yap,et al. Clinical Aspects of Albumin , 1978, Springer Netherlands.
[70] J. Timbrell,et al. Toxicity-related changes in benzene metabolism in vivo. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.
[71] P. Henderson,et al. Urinary mercapturic acid excretion as a biological parameter of exposure to alkylating agents , 1977, International archives of occupational and environmental health.
[72] R. S. Adams. The Future for Insecticides Needs and Prospects , 1977 .
[73] M. Rothschild,et al. ALBUMIN-OSMOTIC FUNCTION† , 1977 .
[74] J. Gillette. Kinetics of Reactive Metabolites and Covalent Binding in Vivo and in Vitro , 1977 .
[75] I. Purchase,et al. Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use , 1976, Nature.
[76] A. Verloop,et al. Development and Application of New Steric Substituent Parameters in Drug Design , 1976 .
[77] L. Hall,et al. Molecular connectivity in chemistry and drug research , 1976 .
[78] E. J. Ariëns,et al. Stereoselectivity and affinity in molecular pharmacology. , 1976 .
[79] Everardus Jacobus Ariëns,et al. Introduction to general toxicology , 1976 .
[80] B. Portmann,et al. Paracetamol metabolism in the rat: relationship to covalent binding and hepatic damage. , 1976, Xenobiotica; the fate of foreign compounds in biological systems.
[81] R. Garner. Testing of some benzidine analogues for microsomal activation to bacterial mutagens. , 1975, Cancer letters.
[82] Gary E. Blau,et al. Partition coefficient to measure bioconcentration potential of organic chemicals in fish , 1974 .
[83] J. L. Allen,et al. Movement of Drugs Across the Gills of Fishes , 1974 .
[84] A. Walpole,et al. A safer substitute for benzidine in the detection of blood , 1974 .
[85] S. Ross,et al. The enzymatic hydrolysis of a series of aminoacylanilides in relation to their nerve blocking effect and toxicity. , 2009, Acta pharmacologica et toxicologica.
[86] H. Sanders,et al. Toxicity, residue dynamics, and reproductive effects of phthalate esters in aquatic invertebrates. , 1973, Environmental research.
[87] E. J. Ariëns. Modulation of Pharmacokinetics by Molecular Manipulation , 1971 .
[88] S. Ross,et al. Stereospecificity of the enzymatic biotransformation of the enantiomers of prilocaine (Citanest). , 2009, Acta pharmacologica et toxicologica.
[89] D. Allsopp,et al. Evidence of the Hydrolysis of Pentachlorophenyl Laurate by Soil Micro-organisms , 1970 .
[90] R. Lefaux. Practical Toxicology of Plastics , 1968 .
[91] E. J. Ariëns,et al. CHOLINERGIC AND ANTICHOLINERGIC DRUGS, DO THEY ACT ON COMMON RECEPTORS? , 1967, Annals of the New York Academy of Sciences.
[92] Hayes Gr,et al. Insecticide Activity in Man, Urinary Excretion of Paranitrophenol by Volunteers Following Dermal Exposure to Parathion at Different Ambient Temperatures , 1963 .
[93] T. S. Scott. Carcinogenic and Chronic Toxic Hazards of Aromatic Amines , 1962 .
[94] A. Crafts. The Chemistry and Mode of Action of Herbicides , 1961 .
[95] C. F. Eno,et al. Toxic Phosphorus Esters , 1961 .
[96] Horace W. Gerarde,et al. Toxicology and Biochemistry of Aromatic Hydrocarbons , 1960 .
[97] McIsaac Rj,et al. Comparison of the effects of inhibition of external, internal and total acetylcholinesterase upon ganglionic transmission. , 1959 .
[98] C. Pfeiffer. Optical isomerism and pharmacological action, a generalization. , 1956, Science.
[99] R. Rosenthal,et al. Use of γ-(4-Nitrobenzyl)pyridine as Analytical Reagent for Ethylenimines and Alkylating Agents , 1955 .
[100] A. Crafts. A Theory of Herbicidal Action. , 1948, Science.